Global Testosterone Cypionate Market Research Report 2023

Publication ID:

PB510233798

Publication Date:

October 9, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Testosterone cypionate, sold under the brand name Depo-Testosterone among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men. It is also used in hormone therapy for transgender men. It is given by injection into muscle or subcutaneously, once every one to four weeks, depending on clinical indication.
The global Testosterone Cypionate market is projected to reach US$ 302.7 million in 2029, increasing from US$ 186 million in 2022, with the CAGR of 6.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Testosterone Cypionate 91制片厂.
Key manufacturers engaged in the Testosterone Cypionate industry include Pfizer, Cipla, Sun Pharmaceutical, Teva, Perrigo and Hikma Pharmaceuticals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Testosterone Cypionate were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Testosterone Cypionate market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Testosterone Cypionate market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Pfizer
Cipla
Sun Pharmaceutical
Teva
Perrigo
Hikma Pharmaceuticals
Segment by Type
200 mg/mL
100 mg/mL
Segment by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Testosterone Cypionate report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Testosterone Cypionate Market Overview
1.1 Product Overview and Scope of Testosterone Cypionate
1.2 Testosterone Cypionate Segment by Type
1.2.1 Global Testosterone Cypionate Market Value Comparison by Type (2023-2029)
1.2.2 200 mg/mL
1.2.3 100 mg/mL
1.3 Testosterone Cypionate Segment by Application
1.3.1 Global Testosterone Cypionate Market Value by Application: (2023-2029)
1.3.2 Primary Hypogonadism
1.3.3 Hypogonadotropic Hypogonadism
1.3.4 Late-Onset Hypogonadism
1.4 Global Testosterone Cypionate Market Size Estimates and Forecasts
1.4.1 Global Testosterone Cypionate Revenue 2018-2029
1.4.2 Global Testosterone Cypionate Sales 2018-2029
1.4.3 Global Testosterone Cypionate Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Testosterone Cypionate Market Competition by Manufacturers
2.1 Global Testosterone Cypionate Sales Market Share by Manufacturers (2018-2023)
2.2 Global Testosterone Cypionate Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Testosterone Cypionate Average Price by Manufacturers (2018-2023)
2.4 Global Testosterone Cypionate Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Testosterone Cypionate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Testosterone Cypionate, Product Type & Application
2.7 Testosterone Cypionate Market Competitive Situation and Trends
2.7.1 Testosterone Cypionate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Testosterone Cypionate Players Market Share by Revenue
2.7.3 Global Testosterone Cypionate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Testosterone Cypionate Retrospective Market Scenario by Region
3.1 Global Testosterone Cypionate Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Testosterone Cypionate Global Testosterone Cypionate Sales by Region: 2018-2029
3.2.1 Global Testosterone Cypionate Sales by Region: 2018-2023
3.2.2 Global Testosterone Cypionate Sales by Region: 2024-2029
3.3 Global Testosterone Cypionate Global Testosterone Cypionate Revenue by Region: 2018-2029
3.3.1 Global Testosterone Cypionate Revenue by Region: 2018-2023
3.3.2 Global Testosterone Cypionate Revenue by Region: 2024-2029
3.4 North America Testosterone Cypionate Market Facts & Figures by Country
3.4.1 North America Testosterone Cypionate Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Testosterone Cypionate Sales by Country (2018-2029)
3.4.3 North America Testosterone Cypionate Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Testosterone Cypionate Market Facts & Figures by Country
3.5.1 Europe Testosterone Cypionate Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Testosterone Cypionate Sales by Country (2018-2029)
3.5.3 Europe Testosterone Cypionate Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Testosterone Cypionate Market Facts & Figures by Country
3.6.1 Asia Pacific Testosterone Cypionate Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Testosterone Cypionate Sales by Country (2018-2029)
3.6.3 Asia Pacific Testosterone Cypionate Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Testosterone Cypionate Market Facts & Figures by Country
3.7.1 Latin America Testosterone Cypionate Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Testosterone Cypionate Sales by Country (2018-2029)
3.7.3 Latin America Testosterone Cypionate Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Testosterone Cypionate Market Facts & Figures by Country
3.8.1 Middle East and Africa Testosterone Cypionate Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Testosterone Cypionate Sales by Country (2018-2029)
3.8.3 Middle East and Africa Testosterone Cypionate Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Testosterone Cypionate Sales by Type (2018-2029)
4.1.1 Global Testosterone Cypionate Sales by Type (2018-2023)
4.1.2 Global Testosterone Cypionate Sales by Type (2024-2029)
4.1.3 Global Testosterone Cypionate Sales Market Share by Type (2018-2029)
4.2 Global Testosterone Cypionate Revenue by Type (2018-2029)
4.2.1 Global Testosterone Cypionate Revenue by Type (2018-2023)
4.2.2 Global Testosterone Cypionate Revenue by Type (2024-2029)
4.2.3 Global Testosterone Cypionate Revenue Market Share by Type (2018-2029)
4.3 Global Testosterone Cypionate Price by Type (2018-2029)
5 Segment by Application
5.1 Global Testosterone Cypionate Sales by Application (2018-2029)
5.1.1 Global Testosterone Cypionate Sales by Application (2018-2023)
5.1.2 Global Testosterone Cypionate Sales by Application (2024-2029)
5.1.3 Global Testosterone Cypionate Sales Market Share by Application (2018-2029)
5.2 Global Testosterone Cypionate Revenue by Application (2018-2029)
5.2.1 Global Testosterone Cypionate Revenue by Application (2018-2023)
5.2.2 Global Testosterone Cypionate Revenue by Application (2024-2029)
5.2.3 Global Testosterone Cypionate Revenue Market Share by Application (2018-2029)
5.3 Global Testosterone Cypionate Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Testosterone Cypionate Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Testosterone Cypionate Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Cipla
6.2.1 Cipla Corporation Information
6.2.2 Cipla Description and Business Overview
6.2.3 Cipla Testosterone Cypionate Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Cipla Testosterone Cypionate Product Portfolio
6.2.5 Cipla Recent Developments/Updates
6.3 Sun Pharmaceutical
6.3.1 Sun Pharmaceutical Corporation Information
6.3.2 Sun Pharmaceutical Description and Business Overview
6.3.3 Sun Pharmaceutical Testosterone Cypionate Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sun Pharmaceutical Testosterone Cypionate Product Portfolio
6.3.5 Sun Pharmaceutical Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Testosterone Cypionate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Testosterone Cypionate Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Perrigo
6.5.1 Perrigo Corporation Information
6.5.2 Perrigo Description and Business Overview
6.5.3 Perrigo Testosterone Cypionate Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Perrigo Testosterone Cypionate Product Portfolio
6.5.5 Perrigo Recent Developments/Updates
6.6 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Corporation Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Testosterone Cypionate Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hikma Pharmaceuticals Testosterone Cypionate Product Portfolio
6.6.5 Hikma Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Testosterone Cypionate Industry Chain Analysis
7.2 Testosterone Cypionate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Testosterone Cypionate Production Mode & Process
7.4 Testosterone Cypionate Sales and Marketing
7.4.1 Testosterone Cypionate Sales Channels
7.4.2 Testosterone Cypionate Distributors
7.5 Testosterone Cypionate Customers
8 Testosterone Cypionate Market Dynamics
8.1 Testosterone Cypionate Industry Trends
8.2 Testosterone Cypionate Market Drivers
8.3 Testosterone Cypionate Market Challenges
8.4 Testosterone Cypionate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Pfizer
Cipla
Sun Pharmaceutical
Teva
Perrigo
Hikma Pharmaceuticals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.